Piramal Pharma LimitedNSE: PPLPHARMA

Press Release Jul 26 2024

· Issued by Piramal Pharma Limited

Filed with NSE · · 21 pages · English

Summary by 6ix AI

Piramal Pharma Limited has announced its consolidated results for the first quarter of the financial year, highlighting significant growth in revenue and EBITDA compared to the previous year. The results presentation includes insights into the company's various business segments, including consumer healthcare and hospital generics, which have shown robust demand and growth.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Piramal Pharma Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024".

Piramal Pharma Limited on 6ix

In the deck

Earlier from Piramal Pharma

Later from Piramal Pharma

All Piramal Pharma news releases